IMU 4.00% 4.8¢ imugene limited

Why IMU is a multi multi bagger, page-22039

  1. 13 Posts.
    lightbulb Created with Sketch. 136
    Thank you for posting this link. It is interesting to note that as per the abstract, it mentioned that "As of Aug 2023, we report early results from seven patients with GI malignancies who received CF33-hNIS alone".

    https://hotcopper.com.au/data/attachments/6057/6057152-615db57f3a5f3caeb6c3dc15a0103a4e.jpg

    We were first notified for this result on 6 November 2023 from the ASX annoucement "Phase 1 CF33-hNIS (VAXINIA) Study Update - Positive Early Signals" and another study update on 17 January 2024.

    https://hotcopper.com.au/data/attachments/6057/6057173-b5ce30540e6c131e80d5552c3dc847f5.jpg

    https://hotcopper.com.au/data/attachments/6057/6057186-9a65ed147e35ff3b62832ac3f097feee.jpg


    There is timing gap of 2 months or more between the results being reported and the results being annouced. Hope the coming 2024 AACR will release more data or results for the period from January 2024 to March 2024 (maybe or maybe not?)

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.